CXCR3 and neoplasm: This TIL-dependent anti-tumoral activity was furthermore validated in B16F10 tumor-bearing Rag2−/− mice, which showed a significantly increased tumor growth when transferred with CXCR3−/− cytotoxic T-lymphocytes (CTLs) compared to WT CTLs [46].